The Manchester Cancer Research Centre (MCRC) was established in 2006 by three founding partners: The University of Manchester, Cancer Research UK and The Christie NHS Foundation Trust. Since its creation, the MCRC has widened its reach to drive forward cancer research in other NHS trusts within Greater Manchester and to link with other cancer-specific funding bodies.
Professor Rob Bristow
A VISION TO TRANSFORM CANCER CARE
Under the leadership of Professor Robert Bristow, the MCRC has a vision to be a world-leading comprehensive centre for translational cancer research – transforming the clinical care of cancer patients by developing and implementing an integrated personalised medicine strategy.
Our strategy harnesses the power of basic and discovery research within the CRUK Manchester Institute, the wider scientific community within The University of Manchester, including the chemical and physical sciences, as well as the research taking place within the clinic.
STRENGTH THROUGH PARTNERSHIP
The Centre is a unique collaboration that brings together the expertise, vision and resources of its partner organisations, all of which have formidable individual reputations in the field of cancer research. International cooperation with institutions in China, Australasia, North America and Europe further enhances our strategic ambition to be one of the top translational cancer research centres in the world.
Our partnership creates the integrated approach essential to progress changes in patient diagnosis and care within the NHS, and important prevention and early detection research, through the Greater Manchester Cancer Plan, which covers a population of over 3 million people.
ENVIABLE HISTORY AND AMBITION
Building upon Manchester’s strong cancer research heritage, the MCRC provides outstanding facilities where scientists, doctors, nurses, and other health professional researchers can work closely together.
Our “Collaborative Town Halls” catalyse these interactions and allow novel Mancunian ideas of highest ambition to be pump-primed within a “Team Science” approach to cancer research.
LEADERS IN EXCELLENCE
We are home to disease specific Centres of Excellence and lead a number of research networks. Our researchers contribute to consortia involving academic and commercial organisations.